Skip to main content

Cannabinoid protects injured brain

No effective drug currently exists to treat brain injury and the mechanisms that control post-trauma events remain largely unknown. In October 4 Nature, David Panikashvili and colleagues from the Hebrew University, Jerusalem, show that the cannabinoid, 2-arachidonoyl glycerol (2-AG) is part of an endogenous system that protects the brain in the period following traumatic injury.Panikashvili et al. observed that after closed head injury in mice the level of endogenous 2-AG was significantly eleva

Written byTudor Toma
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00

No effective drug currently exists to treat brain injury and the mechanisms that control post-trauma events remain largely unknown. In October 4 Nature, David Panikashvili and colleagues from the Hebrew University, Jerusalem, show that the cannabinoid, 2-arachidonoyl glycerol (2-AG) is part of an endogenous system that protects the brain in the period following traumatic injury.

Panikashvili et al. observed that after closed head injury in mice the level of endogenous 2-AG was significantly elevated. Consequently they administered synthetic 2-AG to mice following head injury and found a significant reduction in brain edema, a better clinical recovery, reduced infarct volume and reduced hippocampal cell death compared with control animals. This recovery was further enhanced by additional administration of inactive 2-acyl-glycerols and was dose-dependently attenuated by SR-141761A, an antagonist of the CB1 cannabinoid receptor (Nature, 2001, 413:527-531).

They suggest that this interaction leads to 2-AG suppression of the formation of reactive oxygen ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

Related articles background image
August 2026 Digest cover
August 2026

Epic Fail: Sea-Monkeys Sabotage Fieldwork

When Barry Hicks set out to photograph thrombolites, thousands of unexpected visitors photobombed his underwater images.

View this Issue
Advancing Respiratory Immunity Through Tissue-Resident Memory T Cell Research

Advancing Respiratory Immunity Through Tissue-Resident Memory T Cell Research

Miltenyi
Overcoming Immunotherapy Resistance in Liver Cancer

Overcoming Immunotherapy Resistance in Liver Cancer

Axion Biosystems
Optimizing NGS Library Preparation for Reliable Sequencing Data

Optimizing NGS Library Preparation for Reliable Sequencing Data

Covaris
Using TCR Repertoire Sequencing to Advance Immunology Research

Using TCR Repertoire Sequencing to Advance Immunology Research

Miltenyi

Products

Sino Biological Logo

Sino Biological Launches SuperNuclease ® Pro with Free Trial Program

Sino Biological Logo

Sino Biological Launches Precisely Characterized Full-Length p-Tau217 Protein to Advance Next-Generation Alzheimer’s Biomarker Assay Development

A photo of a scientist placing the Resipher device on a 96-well plate.

Resipher: Continuous Live-Cell Mitochondrial Respiration Monitoring in 96-Well Plates

Lucid Scientific logo
Conceptual image of ice and frost.

The VAULT100 PRO: Inside the most advanced Stirling Ultracold ULT freezer ever built.

Stirling Ultracold logo